Spine BioPharma, Inc.
Pharmaceutical company · New York, United States
Spine BioPharma, Inc. is a pharmaceutical company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $384,798 sold in a notice filed in 2026.
Profile compiled from public records. Is this your company? Request a correction or update
Spine BioPharma at a glance
Typepharmaceutical company
HeadquartersNew York, United States
SEC CIK1852647
What does Spine BioPharma do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $384,798 sold (2026).
Frequently asked questions about Spine BioPharma
Where is Spine BioPharma headquartered?
Spine BioPharma, Inc. is headquartered in New York, United States.
What does Spine BioPharma do?
Spine BioPharma, Inc. is a pharmaceutical company.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences